MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell

Lily Boo1, Wan Yong Ho2, Norlaily Mohd Ali1

  • 11. Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, 43000 Cheras, Malaysia;

Insights

This study characterized breast cancer stem cells (CSCs) in spheroids, revealing enriched CSC properties and identifying 134 differentially expressed microRNAs (miRNAs). These findings suggest potential new biomarkers for breast cancer diagnosis and therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Breast cancer is a leading cause of mortality, with relapse often linked to cancer stem cells (CSCs).
  • Dysregulation of microRNAs (miRNAs) is implicated in breast cancer recurrence and metastasis.
  • Comprehensive characterization of CSCs and miRNA profiles in enriched breast cancer cells is lacking.

Purpose of the Study:

  • To generate and characterize spheroid-enriched breast cancer cells for CSC properties.
  • To comprehensively analyze the miRNA transcriptome in these enriched CSCs.
  • To identify potential novel miRNA biomarkers for breast cancer stem cell diagnosis and targeted therapy.

Main Methods:

  • Generation of spheroid MCF-7 cells in serum-free conditions.
  • Characterization of CSC properties including self-renewal, marker expression, and drug resistance.
  • Next-generation sequencing (NGS) for miRNA expression profiling and differential analysis.

Main Results:

  • Spheroid-enriched cells exhibited enhanced CSC properties, including self-renewal, increased CSC marker expression, and chemoresistance.
  • These cells also showed increased proliferation, migration, invasion, and wound healing capabilities.
  • 134 significantly differentially expressed miRNAs were identified, including 25 up-regulated and 109 down-regulated, with several novel miRNAs linked to chemoresistance and self-renewal.

Conclusions:

  • Spheroid formation enriches breast cancer cells with CSC properties.
  • A distinct miRNA signature is associated with these CSC-enriched cells.
  • Novel miRNAs identified may serve as potential biomarkers for breast cancer stem cell diagnosis and targeted therapeutic strategies.

Related Concept Videos